Skip to content

Effectiveness of the Myofascial Therapy in the Hemophilic Arthropathy of Ankle

Randomized Clinical Study on the Effectiveness of the Myofascial Therapy in the Treatment of the Hemophilic Arthropathy of Ankle

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02825667
Enrollment
65
Registered
2016-07-07
Start date
2016-09-12
Completion date
2017-09-26
Last updated
2017-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemophilia

Keywords

Haemophilia, Ankle, Arthropathy, Pain, Range of motion, Myofascial techniques

Brief summary

Randomized clinical trial to assess the efficacy of a treatment protocol applied fascial therapy in patients with hemophilic arthropathy ankle, oriented to know and describe the observed differences on the dependent variables: range of motion, pain and physical condition. At the same time, the study will determine whether there are adverse effects or bleeding complications as a result of applied physiotherapy treatment.

Interventions

OTHERPhysiotherapy sessions

Physiotherapy by techniques myofascial therapy, in patients with ankle hemophilic arthropathy

Sponsors

Real Fundación Victoria Eugenia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients diagnosed with hemophilia A and B * Adults patients * Patients with hemophilic arthropathy of ankle diagnosed * Patients in prophylactic treatment regimen or on demand treatment with concentrates of FVIII/FIX.

Exclusion criteria

* Patients without ambulation * Patients diagnosed with other congenital coagulopathy (eg, Von Willebrand disease) * Patients who have developed antibodies to FVIII / FIX (inhibitors) * Patients with neurological or cognitive impairments that prevent understanding of questionnaires and test physical * Patients that have not signed the informed consent document.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline bleeding frequency after treatment and at 5 monthsScreening visit, within the first seven days after treatment and after five months follow-up visitEvaluation of the frequency of muscle and joint bleeds through registration. The frequency of bleeding of the ankle joint is measured with a registry given to patients at the beginning of the study.
Change from baseline joint pain of ankle after treatment and at 5 monthsScreening visit, within the first seven days after treatment and after five months follow-up visitChange from joint pain of ankle during treatment and follow-up period at 5 months. The perception of ankle pain will be measured using visual analog scale (scale 0-10).
Change from baseline joint function after treatment and at 5 monthsScreening visit, within the first seven days after treatment and after five months follow-up visitChange from joint health during treatment and follow-up period at 5 months. Measurement instrument: Haemophilia Joint Health Score (scale 0-20).
Change from baseline range of motion after treatment and at 5 monthsScreening visit, within the first seven days after treatment and after five months follow-up visitChange from range of movement of ankle and knee during treatment and follow-up period at 5 months. The range of motion of the ankle joint will be measured using a universal goniometer, using the protocol for measuring joint motion described by Felipe Querol. Measurement instrument: universal goniometer with the protocol to measurement for patients with hemophilia

Secondary

MeasureTime frameDescription
HeightScreening visitHeight of patients
AgeScreening visitAge of patients
WeightScreening visitWeight of patients included in the study

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026